Sale!

MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test” is a specialized diagnostic tool designed to identify mutations in the MLH3 gene, which are linked to an increased risk of developing hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome type 7. This condition is characterized by a higher likelihood of developing colorectal cancer, as well as other types of cancer, at a younger age than the general population. The test is crucial for individuals with a family history of colorectal cancer or those who meet specific clinical criteria suggesting the presence of Lynch syndrome.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed to detect any mutations in the MLH3 gene that are known to contribute to the development of this hereditary cancer syndrome. The results from this test can provide valuable information for affected individuals and their families regarding their risk of cancer, enabling them to make informed decisions about their health, including taking preventative measures or undergoing more frequent screenings.

The cost of the MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test at DNA Labs UAE is 4400 AED. Given the potential life-saving implications of early detection and intervention, this test represents a critical step for at-risk individuals in managing and mitigating the risks associated with hereditary colorectal cancer.

Description

MLH3 Gene Colorectal Cancer Hereditary Nonpolyposis Type 7 Genetic Test

Test Name: MLH3 Gene Colorectal cancer hereditary nonpolyposis type 7 Genetic Test

Components: MLH3 gene

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test gene MLH3

Test Details: MLH3 gene is one of the genes associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. Lynch syndrome is an inherited condition that increases the risk of developing colorectal cancer and other types of cancer, including endometrial, ovarian, stomach, and urinary tract cancers. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations that may be associated with a particular condition or disease. In the case of hereditary nonpolyposis colorectal cancer, NGS testing can be used to detect mutations in MLH3 gene and other genes associated with Lynch syndrome. By performing NGS genetic testing for MLH3 and other relevant genes, healthcare professionals can identify individuals who have an increased risk of developing colorectal cancer and other associated cancers. This information can be used for early detection, prevention, and management strategies to reduce the risk or detect cancer at an early stage when treatment is more effective. It’s important to note that MLH3 mutations are relatively rare compared to other genes associated with Lynch syndrome, such as MLH1 and MSH2. Therefore, MLH3 testing may not be routinely included in all NGS panels for Lynch syndrome. The specific genes included in the NGS panel may vary depending on the laboratory and the specific test ordered. It’s always recommended to consult with a healthcare professional or genetic counselor to determine the most appropriate genetic testing strategy for an individual’s specific situation.

Test Name	MLH3 Gene Colorectal cancer hereditary nonpolyposis type 7 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test gene MLH3
Test Details	MLH3 gene is one of the genes associated with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome. Lynch syndrome is an inherited condition that increases the risk of developing colorectal cancer and other types of cancer, including endometrial, ovarian, stomach, and urinary tract cancers. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variations that may be associated with a particular condition or disease. In the case of hereditary nonpolyposis colorectal cancer, NGS testing can be used to detect mutations in MLH3 gene and other genes associated with Lynch syndrome. By performing NGS genetic testing for MLH3 and other relevant genes, healthcare professionals can identify individuals who have an increased risk of developing colorectal cancer and other associated cancers. This information can be used for early detection, prevention, and management strategies to reduce the risk or detect cancer at an early stage when treatment is more effective. It’s important to note that MLH3 mutations are relatively rare compared to other genes associated with Lynch syndrome, such as MLH1 and MSH2. Therefore, MLH3 testing may not be routinely included in all NGS panels for Lynch syndrome. The specific genes included in the NGS panel may vary depending on the laboratory and the specific test ordered. It’s always recommended to consult with a healthcare professional or genetic counselor to determine the most appropriate genetic testing strategy for an individual’s specific situation.